Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

PPAR alpha may help in hair growth and could be a target for treatment.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

α-MSH may help treat skin inflammation and fibrosis.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Restoring hair follicle immune privilege may help treat alopecia areata.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

HDAC inhibitors help brain cells grow and improve brain function.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.